CANADA LIFE ASSURANCE Co grew its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 14.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 212,681 shares of the medical instruments supplier's stock after purchasing an additional 27,246 shares during the quarter. CANADA LIFE ASSURANCE Co owned about 0.11% of DENTSPLY SIRONA worth $4,034,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Marshall Wace LLP bought a new stake in shares of DENTSPLY SIRONA during the fourth quarter valued at approximately $15,752,000. Gamco Investors INC. ET AL boosted its holdings in shares of DENTSPLY SIRONA by 45.8% during the 4th quarter. Gamco Investors INC. ET AL now owns 96,129 shares of the medical instruments supplier's stock valued at $1,825,000 after buying an additional 30,200 shares in the last quarter. Jump Financial LLC grew its position in shares of DENTSPLY SIRONA by 61.9% in the 4th quarter. Jump Financial LLC now owns 55,573 shares of the medical instruments supplier's stock worth $1,055,000 after buying an additional 21,244 shares during the period. Bridgewater Associates LP grew its position in shares of DENTSPLY SIRONA by 24.4% in the 4th quarter. Bridgewater Associates LP now owns 225,523 shares of the medical instruments supplier's stock worth $4,280,000 after buying an additional 44,171 shares during the period. Finally, XTX Topco Ltd purchased a new position in DENTSPLY SIRONA during the 4th quarter valued at about $693,000. 95.70% of the stock is owned by hedge funds and other institutional investors.
DENTSPLY SIRONA Stock Performance
Shares of DENTSPLY SIRONA stock traded up $0.12 during trading hours on Monday, reaching $13.87. 2,260,426 shares of the stock traded hands, compared to its average volume of 2,970,223. The company has a 50 day moving average price of $15.09 and a 200 day moving average price of $18.25. DENTSPLY SIRONA Inc. has a one year low of $12.16 and a one year high of $31.00. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The firm has a market capitalization of $2.76 billion, a price-to-earnings ratio of -6.70, a P/E/G ratio of 1.80 and a beta of 0.92.
DENTSPLY SIRONA Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.61%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA's payout ratio is -14.07%.
Wall Street Analyst Weigh In
A number of brokerages have weighed in on XRAY. StockNews.com downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Barrington Research reduced their price objective on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a research report on Friday, February 28th. Morgan Stanley cut DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a research note on Tuesday, April 15th. Jefferies Financial Group downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating and reduced their price target for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Finally, Wells Fargo & Company dropped their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research note on Friday, February 28th. Thirteen analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $22.58.
View Our Latest Analysis on XRAY
Insider Transactions at DENTSPLY SIRONA
In other news, Director Gregory T. Lucier bought 15,142 shares of the firm's stock in a transaction on Monday, March 3rd. The shares were bought at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.52% of the stock is currently owned by company insiders.
About DENTSPLY SIRONA
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
See Also

Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.